Answers are grounded in this paper and cite their sources.
Demonstrates biological activity in cancer and infection models, suggesting potential therapeutic uses.
A heteroleptic titanium(IV) complex, [N,N′-ethylene-bis(3-methoxysalicylaldimine)(4-methylphenolate)titanium(IV)], was synthesized through the reaction of two distinct chelating ligands with titanium tetra-isopropoxide. The complex crystallized in the non-centrosymmetric orthorhombic space group Fdd2, with its bulk purity confirmed via powder X-ray diffraction. Characterization was performed using elemental analysis, UV–visible, FTIR, 1H NMR and 13C NMR spectroscopies and mass spectrometry, while thermal stability was evaluated via thermogravimetric analysis from 40 to 600°C. Hirshfeld surface analysis revealed that crystal packing is primarily driven by C…H (28.5%) and O…H (14.0%) interactions. A HOMO–LUMO energy gap of 3.17 eV suggests high kinetic stability, and non-covalent interaction analysis further localized the intermolecular forces within the lattice. Biological assays demonstrated moderate antibacterial and antifungal efficacy against E. coli, S. aureus, C. albicans and C. tropicalis. The complex was tested for cytotoxicity against lung (A549), breast (MCF-7) and cervical (HeLaS3) cancer cell lines. The findings were supported by molecular docking studies, which yielded a binding affinity of −7.11 kcal mol−1 (4ZXT), −6.59 kcal mol−1 (6I2I) and −6.54 kcal mol−1 (4ZVM).
No takes yet. Share an insight, caveat, or question.
Muthuraj et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: